ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 42372208

Implementing Timely Germline Genetic Testing for Patients With Pancreatic Cancer Using a Genetics Copilot for Point-of-Care Education and Health Assessment.

Moravec S and 28 others. JCO Precis Oncol, 2026. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Implementing Timely Germline Genetic Testing for Patients With Pancreatic Cancer Using a Genetics Copilot for Point-of-Care Education and Health Assessment. Papers, record 42372208. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42372208

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Implementing Timely Germline Genetic Testing for Patients With Pancreatic Cancer Using a Genetics Copilot for Point-of-Care Education and Health Assessment.
PubMed
Journal
JCO Precis Oncol
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors29

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Moravec SSophie
2Barton LVLaura V
3Suresh RRevathy
4Hayward LLaura
5Schmidlen TTara
6Rivera JNRJessica N Riverahttps://orcid.org/0000-0002-6675-0037
7Basinski TTonihttps://orcid.org/0009-0002-9537-578X
8Alhassan SSolomon
9Nardella NNicolehttps://orcid.org/0009-0001-7392-6336
10Oraiqat AAdrianna

1 to 10 of 29Source PubMed

See all 29 authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Pancreatic NeoplasmsMajor topic
Genetic TestingMajor topic
Carcinoma, Pancreatic DuctalMajor topic
Point-of-Care TestingMajor topic
Humans
Female
Male
Middle Aged
Aged
Germ-Line Mutation

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R37 CA229810NCI NIH HHSUnited StatesR37CA229810PubMed

Source NIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139,456,541PARP Inhibitors in Pancreatic Cancer with Homologous Recombination Repair Gene Mutations: A Single-Institution Experience.Cancers (Basel)2024https://conductscience.org/library/papers/39456541PubMed
233,429,865Clinical Significance of Germline Cancer Predisposing Variants in Unselected Patients with Pancreatic Adenocarcinoma.Cancers (Basel)2021https://conductscience.org/library/papers/33429865PubMed
331,642,931Assessment of Diagnostic Outcomes of RNA Genetic Testing for Hereditary Cancer.JAMA Netw Open2019https://conductscience.org/library/papers/31642931PubMed
435,713,757Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake.Fam Cancer2023https://conductscience.org/library/papers/35713757PubMed
518,951,446Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.Hum Mutat2008https://conductscience.org/library/papers/18951446PubMed
633,439,686Implementing Systematic Genetic Counseling and Multigene Germline Testing for Individuals With Pancreatic Cancer.JCO Oncol Pract2021https://conductscience.org/library/papers/33439686PubMed
734,556,502Oncology clinic-based germline genetic testing for exocrine pancreatic cancer enables timely return of results and unveils low uptake of cascade testing.J Med Genet2022https://conductscience.org/library/papers/34556502PubMed
834,133,209Therapeutic Implications of Germline Testing in Patients With Advanced Cancers.J Clin Oncol2021https://conductscience.org/library/papers/34133209PubMed
935,445,726Pancreatic Ductal Carcinoma Risk Associated With Hereditary Cancer-Risk Genes.J Natl Cancer Inst2022https://conductscience.org/library/papers/35445726PubMed
1025,741,868
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Genet Med2015https://conductscience.org/library/papers/25741868PubMed

1 to 10 of 34

See all 34 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

None in this release.

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42372208

GET https://conductscience.org/api/papers/v1/42372208/authors?page=2

API referenceFor AI assistants